These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 6450306)

  • 1. [Acute action of nifedipine in patients with obstructive and nonobstructive asymmetrical septum hypertrophy (ASH)].
    Békés M; Cserhalmi L; Glavanov M; Csukás A; Szilágyi M; Huszár G
    Med Welt; 1980 Sep; 31(39):1408-11. PubMed ID: 6450306
    [No Abstract]   [Full Text] [Related]  

  • 2. [Nifedipine in the treatment of hypertrophic non-obstructive cardiomyopathy].
    Senn M; Hess OM; Krayenbühl HP
    Schweiz Med Wochenschr; 1982 Sep; 112(38):1312-7. PubMed ID: 6215710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute effects of nifedipine in hypertrophic cardiomyopathy. Echocardiographic and hemodynamic study].
    Terrosu P; Dore L; Sannia L; Piras L; Ibba GV
    Boll Soc Ital Cardiol; 1981; 26(12):1973-7. PubMed ID: 6892233
    [No Abstract]   [Full Text] [Related]  

  • 4. Nifedipine in hypertrophic cardiomyopathy.
    Pouleur H; Rousseau MF
    Circulation; 1982 Aug; 66(2):478-9. PubMed ID: 7201360
    [No Abstract]   [Full Text] [Related]  

  • 5. [Long-term therapy of hypertrophic obstructive and non-obstructive cardiomyopathy with nifedipine in comparison to propranolol].
    Cserhalmi L; Assmann I; Glavanov M; Rev J; Kelecseńeyi Z
    Z Gesamte Inn Med; 1984 Jul; 39(14):330-5. PubMed ID: 6435321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of nifedipine therapy on hypertrophic obstructive cardiomyopathy.
    Fedor JM; Stack RS; Pryor DB; Phillips HR
    Chest; 1983 Apr; 83(4):704-6. PubMed ID: 6682029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Beta-adrenergic blockers and calcium antagonists in hypertrophic cardiomyopathy].
    Korovina EP
    Klin Med (Mosk); 1998; 76(12):30-5. PubMed ID: 10067289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of the delayed-action form of korinfar in arterial hypertension, stenocardia and hypertrophic cardiomyopathy].
    Barats SS; Smolenskaia OG; Klets FKh; Zubareva TV; Zakroeva AG; Kots IaI; Tenchurina LR
    Ter Arkh; 1996; 68(1):39-42. PubMed ID: 8644029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of hemodynamic parameters after administration of nifedipine in hypertensive patients].
    Varricchio M; Cacciapuoti F; Russo R; Giunta R; Verza M; Grandillo F
    Minerva Cardioangiol; 1980; 28(1-2):59-68. PubMed ID: 7366854
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the action of nifedipine on the ischemic myocardium using ergometric and pharmacological tests].
    Ravazzi PA; Taverna G; Ivaldi M; Anfossi F
    Boll Soc Ital Cardiol; 1978; 23(10):1707-12. PubMed ID: 261834
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemodynamic effects of nifedipine in patients with obstructive coronary disease and depressed left ventricular function].
    Rovelli EG; Parenti GF; Carnovali M
    Boll Soc Ital Cardiol; 1981; 26(10):949-55. PubMed ID: 7349177
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of adalat (nifedipine) on left ventricular hemodynamics in angina pectoris: comparative study with propranolol.
    Kurita A; Ogawa T; Kanazawa M; Hamamato H; Mabuchi G
    Br J Clin Pract Suppl; 1980; 8():32-6. PubMed ID: 6781515
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effects of nifedipine during rehabilitation of patients with aortocoronary bypass].
    Cerri B; Grasso S; Buonomini G; Cefis M; Costanza G; Pesciatini F
    Minerva Cardioangiol; 1981 Sep; 29(9):483-90. PubMed ID: 6975900
    [No Abstract]   [Full Text] [Related]  

  • 14. Cardiac amyloidosis with asymmetrical septal hypertrophy and deterioration after nifedipine.
    Griffiths BE; Hughes P; Dowdle R; Stephens MR
    Thorax; 1982 Sep; 37(9):711-2. PubMed ID: 6891504
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic evaluation of nifedipine in hypertensive subjects].
    Bonaduce D; Ferrara N; Petretta M; Romano E; D'Ascia C; Sansone A; Rengo F
    Boll Soc Ital Cardiol; 1980; 25(1):47-53. PubMed ID: 7236428
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nifedipine in the treatment of essential hypertension].
    Condorelli M; Bonaduce D; Ferrara N; Petretta M; De Caprio L; Rengo F
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II7-12. PubMed ID: 6763269
    [No Abstract]   [Full Text] [Related]  

  • 17. [The hemodynamic effects of nifedipine in congestive cardiomyopathy (author's transl)].
    Schiavoni G; Mazzari M; Scabbia E; Coppola E; Domenichelli B; Manzoli U
    G Ital Cardiol; 1980; 10(2):161-6. PubMed ID: 7372031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamic effects of nifedipine in association with nitroderivatives and betablocking drugs (author's transl)].
    Aquaro G; Belli R; Rey L; Pavia M; Idone P
    G Ital Cardiol; 1980; 10(10):1340-8. PubMed ID: 7239080
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased sensitivity of left ventricular relaxation to inotropic interventions in patients with coronary artery disease: comparison with normal subjects, mitral stenosis and asymmetric septal hypertrophy.
    Rousseau MF; Pouleur H; Detry JM; Brasseur LA
    Eur Heart J; 1980 Dec; 1(Suppl B):37-41. PubMed ID: 6291944
    [No Abstract]   [Full Text] [Related]  

  • 20. Different pathophysiology of cardiac hypertrophy in hypertension and hypertrophic cardiomyopathy.
    Takeda A; Takeda N
    J Mol Cell Cardiol; 1997 Nov; 29(11):2961-5. PubMed ID: 9405171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.